ascopubs.org

Effectiveness of the Quadrivalent Human Papillomavirus Vaccine Against Cervical Dysplasia in Manitoba, Canada

Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management Females ≥ 15 years old who received the QHPV vaccine in Manitoba between September ...
Healio

Cervical dysplasia risk in autoimmune hepatitis ‘largely driven’ by immunosuppression

Please provide your email address to receive an email when new articles are posted on . Women with autoimmune hepatitis appear at greater risk for cervical dysplasia, HPV infection and subsequent ...
Nasdaq

Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV ...

- Data show that Vaxart’s HPV vaccine constructs stimulate specific T cell immune responses, reduce tumor size, and increase survival in an animal model of human papillomavirus (HPV)-related ...
Morningstar

Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China

Results provide important clinical evidence to support ApolloBio's future regulatory submission in China of VGX-3100, INOVIO's DNA immunotherapy candidate ApolloBio's new clinical results further ...